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Abstract:
Introduction:
Dementia is a major public health issue both in the United States and worldwide. Alzheimer’s disease
(AD) is widely considered to be the most prevalent type of dementia. While the hallmark AD symptom is
profound memory loss, patients also commonly experience changes in personality and behavior. These
changes often include depression, anxiety, social withdrawal, mood swings, irritability and aggression,
changes in sleeping habits, and delusions.
Background:
Several studies have established a mechanistic link between traumatic brain injury (TBI) and the
development of AD. However, it is unknown whether TBI contributes to the personality/behavior changes
observed in many AD patients. The current study examined a possible association between TBI and
psychiatric conditions in patients who present with clinically diagnosed dementia due to AD.
Methods:
Participants in the current study were sampled from the National Alzheimer’s Coordinating Center
dataset. Only participants who had AD at the time of their most recent assessment were included in the
study (N=10,511). Logistic regression was used to analyze the association between TBI and adverse
psychiatric outcomes (defined as presence of psychosis or agitation/aggression) in patients with AD.
Confounding variables, including age, gender, education, and dementia severity, were included in final
regression models.
Results:
Agitation/Aggression:
This study found an association with alcohol abuse (OR: 1.87), age group of 65-74 (OR: 1.41), and
having active diabetes in both the mild (OR: 1.21) and moderate (OR: 1.25) states of AD. A remote
history of seizure in moderate AD had one of the strongest associations with increased odds of
agitation/aggression (OR: 2.24). In those with severe AD and agitation/aggression, a protective
association was found in those age 85+ (OR: 0.66), and in those with a recent history of urinary
incontinence (OR: 0.59).
Psychosis:
The lowest educational attainment group had the highest risk of developing psychosis, with mild AD & 012 years of education (OR: 1.67), those with moderate AD & 0-12 years of education (OR: 1.76), in those
with moderate AD & 13-16 years of education (OR: 1.53). At a mild stage of AD there was a suggestive
association with urinary incontinence (OR: 1.20). In addition, being age 85+ at a severe stage of AD had a
suggestive protective association (OR: 0.67).
Conclusion:
No significant association was found between TBI and psychiatric symptoms in persons with AD.
However, there was evidence of an association between age, diabetes, alcohol abuse, urinary incontinence
and seizures with agitation/aggression. Age, education level, and a recent history of incontinence are
associated with increased odds of developing psychosis.
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Introduction:
Dementia is a major public health issue not only in the United States but also worldwide.
While there are several types of dementia, Alzheimer’s disease (AD) is generally considered to
be the most prevalent.1 The Diagnostic and Statistical Manual of Mental (DSM) Disorders V
classifies AD into two categories: major neurocognitive disorder (ND) and mild neurocognitive
disorder.2 These two categories can be further subdivided into probable and possible cases. A
probable diagnosis of AD is assigned – either through genetic testing or familial history – based
on evidence of the AD genetic mutation.2 In addition, a probable case must have a clear
presentation of memory decline and decline of at least one other cognitive function. A possible
diagnosis of AD is given when there is no evidence of an AD genetic mutation but there is clear
evidence of memory and information retention issues as well as steady cognitive decline without
extended plateaus.2 Both possible and probable diagnoses must present without evidence of
mixed etiology.2 While this is how AD is classified by the DSM-V, it is important to note that
this is only one form of diagnostic classification. There are several methods that clinicians use to
diagnose AD. Some of these methods include a thorough medical history, mental status testing,
physical and neurological exams, imaging scans, and blood tests to rule out other types of
dementia.3
Traditionally, the hallmark AD symptom is memory loss. However, people with AD also
commonly experience disorientation; difficulty with spatial relationships, speaking and writing,
judgment, planning, and/or carrying out familiar tasks; and changes in personality and behavior.
These behavior and personality changes are generally characterized by symptoms such as
depression, anxiety, social withdrawal, mood swings, distrust, irritability and aggression,

changes in sleeping habits, wandering, loss of inhibition, and delusions.1 Memories established
early in life are often the last to be lost during the course of the disease.1
AD places a heavy cognitive disease burden on the U.S. population, with 60-90% of all
dementia cases being attributed to AD.2 The overall prevalence of dementia increases with age.2
Of the people diagnosed with AD, 7% are between the ages of 65 and 74, 53% are between the
ages of 75 and 84, and 40% are 85+ years old.2 In 2013, as defined by the ICD-9, AD was one of
the 15 leading causes of death in the U.S.4 In 2013, there were 84,767 total deaths attributed to
AD.4,5 Mortality increased from 1999 to 2013,4 with the majority of deaths occurring between the
ages of 75 and 84; for people older than 85 there was an increase in mortality rates until 2008.4
Mortality in the 75-84 age range has begun to decline; in 1999, the mortality rate of AD was
129.5 deaths per 100,000 people, with the rate peaking in 2008 at 192.5 deaths per 100,000
people and later declining to 171.6 deaths per 100,000 people in 2013.4 Additionally, deaths
among those older than age 85 have begun to decrease, with the all-time highest death rate to
date occurring in 2008 at 1,002.2 deaths per 100,000 people.4 By 2013, this rate had decreased to
929.5 deaths per 100,000 people.4 The age-adjusted rate increased from 16.5 deaths per 100,000
people in 1999 to 25.8 deaths per 100,000 people in 2008, with a slight decrease between 2008
and 2013 to 23.5 deaths per 100,000 people.4
Although there does not appear to be any single definitive cause of AD, it is generally
agreed that several risk factors contribute to the development of disease.1 Genetic and
physiological risk factors for AD include age, genetic susceptibility (apolipoprotein E4 or
APOE), Down’s syndrome, vascular problems, and environmental risk factors, including
traumatic brain injuries (TBI).2 Upon autopsy, individuals with AD often show evidence of
cortical atrophy and high levels of amyloid-predominant neuritic plaques and/or tau-predominant
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neurofibrillary tangles.2 These plaques and tangles are thought to contribute to brain shrinkage
through neuron death, which causes many of the symptoms of AD.6
The purpose of this study was to assess the potential link between TBI history and
psychiatric conditions in patients who present with medically diagnosed dementia due to AD. It
evaluated the association between AD-related psychiatric symptoms or diagnosed psychiatric
illnesses and reported TBIs.

Literature Review:
This literature review was conducted using PubMed, an online repository of medical and
health-related peer-reviewed journals articles maintained by the National Institutes of Health.
The main key words employed in the literature review were: Alzheimer’s disease, psychiatric
conditions, traumatic brain injuries, dementia, increased risk, risk factors, and increased odds.
A TBI is the loss or alteration of consciousness, with or without prograde and retrograde
amnesia, that involves immediate physical and neurological symptoms ranging from mild to
severe.7 TBIs can cause several types of chronic physical, cognitive, and behavioral issues. The
most common form of brain injury is an acute mild TBI or concussion.7 Several epidemiological
studies have tried to establish a mechanistic link between a TBI as an exposure and the
development of AD as an outcome. These studies have produced conflicting results. Both a study
in Japan by Kondo et al. and a study in Kentucky by Abner et al. found an increased risk of
developing AD to be associated with a history of head injury, though results varied slightly
between studies.8,9 Using a case control study to examine risk factors for AD, Kondo et al. found
that a head injury with a loss of consciousness (LOC) increased the odds of developing AD 5.5
times as compared with having no history of head injury with a LOC (p<0.001).8 Abner et al.
found that the odds of developing dementia among those with a history of TBI was only
University of Kentucky
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significantly increased in males (OR 1.47, 95% CI 1.03 to 2.09); and the odds of developing AD
in women with a history of TBI was increased but not found to be statistically significant (OR
1.18, 95% CI 0.83 to 1.68).9 Two studies, the Rotterdam study and the Adult Changes in
Thought study found that there was no statistically significant association between the
development of AD and having a history of head injury.9 Plassman et al. had a mixed result with
increased rates in those with moderate (HR=2.32, p-value<0.05) and severe head injury
(HR=4.51, p-value<0.05), however decreased risk in those with mild head injuries (HR=0.76, pvalue>0.05), though the latter was not found to be statistically significant.12
Hyperphosphorylated tau, the main component in neurofibrillary tangles, is one of the
pathological hallmarks of AD. Higher levels of tau are found in those who died with AD than in
those who did not. A study by Jeromin et al. found that soldiers with a self-reported history of
TBI had higher blood levels of Tau than those who had not experienced a TBI (p=0.03).13 While
an elevated tau level is expected in individuals with TBI, it was initially believed that these
levels only remained high for a few hours immediately following the injury.13 However, the
study by Jeromin et al. indicated that these levels remained elevated for up to 3-18 months.13
This study also found that the severity of total post-concussive symptoms was significantly
correlated with total Tau concentrations in those with self-reported TBI (p=0.003).13
Furthermore, the study indicated that people who suffered multiple TBIs maintained long-term
elevated tau levels. The level of measured tau was directly correlated with the severity of
symptoms experienced. The long-term health effects of elevated tau levels are currently
unknown, but it is possible that elevated tau levels could be associated with a history of TBI and
increased risk of AD, as elevated tau is thought to be one of the risk factors in AD development.
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However, a major limitation to this study is that it does not report whether the Tau measured was
the phosphorylated Tau found in neurofibrillary tangles.
Another study used mice with AD as a model and induced TBIs to observe the resulting
changes in behavior. This study specifically examined how ß-amyloid (the main component in
neuritic plaques) contributes to the neuro-inflammatory response post-concussive injury.2,14 This
study showed a difference in the recovery of mice with higher levels of ß-amyloid as compared
with mice with lower levels of ß-amyloid.14 This finding suggests a possible correlation between
TBIs and AD-associated outcomes. Although there is some research on this connection between
TBIs and AD outcomes, further analysis would help improve prediction of negative health
outcomes for AD sufferers.
AD, an already burdensome disease, becomes more difficult to manage when the patient
also suffers from neuropsychiatric symptoms (NPS).15 Some studies have found that those with
AD who suffer from NPS will have an expedited decline, both functionally and cognitively.16,17
They also have been known to have a lower quality of life, often with earlier institutionalization
and accelerated mortality rates.18-22 Those who suffer from delusions or agitation had an
increased risk of being institutionalized as compared to those who did not have delusions or
agitation, with a hazard ratio of 5.74 (95% CI: 1.94-16.96) and 4.70 (95% CI: 1.07-20.70),
respectively.22 The presence of overwhelmed caregivers was often found to be a main mediating
variable for institutionalization in those with delusions and or agitation.22 Those suffering from
hallucinations were found to have an increased mortality rate: HR=2.59 (95% CI: 1.09-6.16).22
Some studies have found that NPS are predictors for the future onset of dementia in those with
mild cognitive impairment (MCI).23 A longitudinal study of a cohort who presented with MCI at
the time of study found that those who had NPS were at an increased risk of developing AD:
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HR=1.35 (95% CI: 1.09-1.66).23 Due their close linkage with adverse health events and
decreased quality of life of those with AD, NPS have been shown to be important targets for
prevention.15 Currently, most research on the association between NPS and AD conceptualizes
NPS as a predictor of AD. Limited research has explored the risk factors for those who have AD
and subsequently develop NPS.
Psychosis, defined as suffering from hallucinations and delusions, is a common
occurrence in patients with AD, with one study reporting a prevalence of 41%.24 Psychosis rates
in patients with AD have been shown to be higher in those who reside in nursing facilities, with
more than 66% suffering with symptoms for a time period longer than 10 weeks.24 Imaging
studies indicate that NPS symptoms can be caused by the neurodegeneration of areas associated
with these psychiatric symptoms.24 Single photon emission tomography (SPECT) scans have
shown that patients suffering with dementia and psychosis usually manifest with preferential
involvement of the frontal lobe and/or the limbic regions, as well as hypoperfusion in the parietal
lobe.24 There also tended to be gender differences when examining perfusion positron emission
tomography (PET) scans, with females having lower perfusion in the right inferior-lateral frontal
cortex and inferior temporal regions as compared to those who were not psychotic and males
having higher perfusion in the right striatum.24 SPECT scans also have shown decreased blood
flow to the frontal and temporal regions of the brain in those suffering with agitation.24
However, research has shown that neuropathological explanations are not sufficient to
explain why NPS happen in those with AD.24 It is likely that a combination of factors (e.g.,
environmental, biological abnormalities, psychiatric history, family history, genetic
susceptibility) contribute to NPS.24 Neuropathological studies on psychosis have shown an
increased deposition of neuritic plaques and neurofibrillary tangles in the areas associated with
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varying psychotic symptoms when patients with AD are autopsied.24 In a prospective
clinicopathologic study, those who had AD confirmed by autopsy were found to have less severe
neuron loss in the parahippocampal gyrus and non-significant lower neuron numbers in the
serotonergic dorsal raphe nucleus than patients who had no NPS symptoms.25
Studies have shown concussions, or TBIs, to be linked not only with cognitive
impairment but also with psychiatric symptoms. Sports-related head injuries have been
demonstrated to be highly associated with MCI and depression in retired football players.26 A
prospective longitudinal study that examined symptoms and recovery time in those who suffered
from a mild TBI found that a subset population of people with persistent symptoms post-injury
suffered from psychological symptoms such as depression, traumatic stress, and low resilience.27
A cross-sectional study on collegiate athletes concluded that athletes with a history of concussion
displayed changes in their frontal-alpha and frontal-beta asymmetry by an electro
encephalogram, which are indicative of increased general mood disturbances when compared to
the controls (p < 0.05).28 These findings also were correlated with self-reported depression and
anxiety in those who suffered from frontal-alpha asymmetry and self-reported anger/aggression
in those with alterations in beta-asymmetry.28 However, these correlations were found to be
significant only in the athletes who had a history of concussion.28
While the current literature address NPS and their effects in people with AD on multiple
levels, continued research is needed on NPS predictive risk factors. This would aid in a holistic
understanding of the potential causes and risk factors for these symptoms in those with dementia
due to AD. In addition, this would aid in a more personalized approach in symptom prevention
and management, as well as aid in the enhancement of quality of life.
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Methods:
Study Design and Data
This study used a cross-sectional design to examine whether those with AD and a history
of TBI had increased odds of NPS, primarily psychosis and agitation/aggression. These two
conditions were chosen because they often are the primary psychiatric conditions that cause a
person with AD to enter into early institutionalization.15
Data for this project were obtained from the National Alzheimer’s Coordinating Center
(NACC) Uniform Data Set and Neuropathology databases (December 2014 freeze) with full
neuropsychiatric inventory. Dr. Erin Abner of the University of Kentucky’s College of Public
Health and Sanders-Brown Center on Aging submitted the data request on December 7, 2015,
with approval granted the same day. Data then were downloaded from the NACC’s online portal.
Data in this study are representative of Version 1 & 2 of the protocols conducted by the NACC.
The NACC Uniform Dataset consists of annual examinations of study participants, or by a coparticipant (usually a family member or close friend), at each of the ~30 federally funded
Alzheimer’s Disease Centers (ADCs). All locations have different qualifying criteria for
participation in the study. Participants may have any cognitive status. The total number of
assessments included in the original data set amounted to 103,710, with 105 variables. Each
individual participant could have multiple data lines due to annual follow-up visits to assess
cognitive function. All research activities were approved by an Institutional Review Board (IRB)
at the research center at which the participant was recruited and followed. All subjects provided
written informed consent. No IRB approval was needed for this secondary analysis of the deidentified NACC data.
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Variable Selection
Data for the current study were limited to the most recent clinical assessment available.
Participants were limited to those with a clinical diagnosis of AD dementia at the last assessment
(N=10,511). Variables of interest were retained, and several new variables were generated,
including dementia due to AD, categorical educational attainment, categorical age groups,
presence of agitation/aggression, psychosis, and TBI, and a new variable for race that collapsed
Asian and Pacific Islander categories due to low numbers. TBI was defined as the participant
having indicated that during their lifetime they had suffered from a recent (current) or remote
(historically far-off) head injury, which had resulted in a brief loss of consciousness (LOC), an
extended LOC, or a chronic deficit. All those who indicated no to the three types of head injury
reported on were coded as having no history of TBI. In contrast, those who answered yes to one
or multiple types were coded as having a history of TBI. Levels of education were categorized as
0-12 years (12=High School Diploma), 13-16 years (16=Bachelors Degree), 17-18 years
(18=Masters Degree), and 18< years (18+ =Doctoral Degree). These ranges were chosen to
reflect common U.S. educational attainment levels. In addition, the age groups were categorized
as <65, 65-74, 75-84, and 85+ because these are the same groupings used by the CDC to report
incidence and prevalence rates of AD in the U.S. The remaining variables then were assessed for
missing-ness using frequency counts. Variables of interest included: AD status; AD severity;
TBI status; psychosis status; agitation/aggression status; medical history related to incontinence,
stroke, seizure, bypass, hypertension, heart attack, use of psychiatric drugs, smoking status, and
alcohol or non-prescription drug use/abuse; and demographics such as age, gender, race, and
years of educational attainment. No variable of interest had greater than a 15% missing rate, thus
all variables were included in the analysis.
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Statistical Analysis
Logistic regression, with dependent variables of agitation/aggression and psychosis, was
used to estimate odds ratios for risk factors of interest. Initially, a bivariate analysis of each
variable of interest was conducted for both dependent variables. Using the outcomes of these
bivariate analyses, a complete model was generated. The model was further refined using
backwards elimination to establish which variables should be kept in the final regression model.
Based on these results, history of heart disease, history of cardiac bypass, and history of
hypertension were eliminated from the model. Diabetes, history of drug abuse, and history of
alcohol abuse were retained in the model, despite backwards elimination indicating they may not
be necessary. This decision was made because diabetes, drug use, and alcohol abuse have a close
relationship with an outcome of interest (agitation/aggression). Models were run with
educational attainment and age as both categorical and continuous variables. Both education and
age had higher significance levels when modeled as categorical rather than continuous variables;
therefore, these two variables were run categorically. The final models then were run using
selected variables. Due to wide confidence intervals, a secondary analysis of the model was
conducted to identify unnecessary variables. This secondary analysis suggested that smoking
status, prescription psychiatric drug use, gender, and race should be removed from the model in
an effort to increase power. Akaike’s Information Criterion was used to compare the models.
Due to minimal change in these numbers as well as minimal changes in confidence intervals,
these variables were excluded from the final model. Each model then was stratified by AD
severity, which is associated with prevalence of NPS, using the Clinical Dementia Rating Global
(CDRGLOB) score, ranging from 1 to 3 (1=mild dementia, 2=moderate dementia, 3=severe
dementia), to generate six separate outputs. Additional variables were created for TBI, psychosis,
and agitation/aggression to represent at which visit each participant was diagnosed with
University of Kentucky
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psychosis, agitation/aggression, and/or TBI. The frequency of each was calculated to ensure that
the majority of TBIs occurred at or before the diagnosis of psychological symptoms, which
helped to ensure that exposure preceded the onset or diagnosis of psychological disorders.

Results:
Table 1.1 is a summary of participant demographics. The participants were 43.7% male
and 56.3% female. In addition, those with TBI tended to be, at 60% to 40% female. The number
of participants was highest in the age group of 75-84 years (41.5%) and lowest in the age group
of less than 65 years (10.9%). While the percentage of people ages 75-84 is representative of the
average percentage with AD in this age group, the number of participants in the age group of 6574 years is higher than average at 21.8%, and the age group of 85+ years is lower than average at
only 25.8%.2 The percentage of white participants is high in this study, with 80.4% of the study
participants identifying as white and only 11.6% identifying as black or African American, 0.7%
as American Indian, 1.9% as Asian/Pacific Islander, and 3.2% as multiracial. Only 10.2% of
study participants reported having suffered from a TBI. Of those that reported a TBI, the highest
rate was in the participants who reported a TBI with a brief loss of consciousness (75.4%).
Educational attainment was evenly distributed among those who had a high school education or
less (38.0%) and those who had a college degree (37.4%). The proportion of substance abuse
among those who had experienced a TBI was higher than among those who had not. Of those
who had experienced a TBI, 11.0% reported abusing alcohol and 1.8% reported abusing drugs.
Table 2.1-2.2 shows the bivariate, crude values of all variables that were ultimately
included in the adjusted models. All results are presented in odds ratios and stratified by AD
University of Kentucky

Walch | 14

severity (mild, moderate, and severe). In those with mild AD and agitation and aggression, there
were significantly increased odds of being in the age group of 65-74 years (OR=1.42, pvalue=0.004) and having diabetes (OR=1.24, p-value=0.03), when compared to those age <65
and those who never had diabetes. There also was a marginally significant between abuse of
alcohol, both recent (OR=1.60, p-value=0.09) and remote (OR=1.30, p-value=0.07) when
compared to those who had no history of alcohol abuse. In those with moderate AD and agitation
and aggression, there were increased odds of having diabetes, when compared to those who had
no diabetes (OR=1.26, p-value=0.05). Conversely, being in the age group of 85+ years had a
protective effect (OR=0.75, p-value=0.04), when compared to those in age group <65. In those
with severe AD and agitation and aggression, there was a decrease in odds of having a history of
seizures both recent (OR=0.62, p-value=0.01) and remote (OR=0.64, p-value=0.05), and having
urinary incontinence (OR=0.66, p-value=0.0002), using those with no history of seizures or
urinary incontinence as a comparison group. In addition, there is a suggested association with
those 85 and older (OR=0.75, p-value=0.07) using those in age group <65 as a control.
In those with mild AD and psychosis, there were increased odds of having urinary
incontinence (OR: 1.23, p-value=0.04), when compared to those with no history of urinary
incontinence. Those with moderate AD had increased odds of being aged 65-74 (OR=1.38, pvalue=0.05), having 0-12 years of education (OR=1.38, p-value=0.001), and having 13-16 years
of education (OR=1.25, p-value=0.01) when using those in age group <65 and educational
attainment of 18+ years as controls. Having a remote history of urinary incontinence appears to
have a protective affect (OR=0.65, p-value=0.07), when compared to those who had no history
of incontinence in those with moderate AD. Those with severe AD had increased odds of having
0-12 years of education (OR=1.58, p-value=0.01), diabetes (OR=1.38, p-value=0.02), and a

University of Kentucky

Walch | 15

suggested association with alcohol abuse (OR=6.66, p-value=0.09) using 18+ years of education,
no history of diabetes, and no history of alcohol abuse as comparison groups.
Tables 3.1 presents the association between agitation and aggression and TBI, stratified
by severity of Alzheimer’s disease as mild, moderate, and severe. Those with mild AD and
agitation/aggression had an increased odds of being in age group 65-74 (OR=1.41, pvalue=0.007) when compared to those in age group <65, and those with recent alcohol abuse,
using those with no history of alcohol abuse for comparison (OR=1.87, p-value=0.04). There
was also a suggestive association in this group with those who had a recent history of diabetes
compared to those with no diabetes, with increased odds of 21% (OR=1.21, p-value=0.07). In
those with moderate AD and agitation/aggression, there was a suggestive association between
diabetes (OR=1.25, p-value=0.08), a remote history of seizures (OR=2.24, p-value=0.05), and
remote urinary incontinence (OR=1.18, p-value=0.08), when compared to those who had no
history of those conditions. In those with severe impairment due to AD, both those in age group
85+ (OR=0.66, p-value=0.07) and a recent history of seizures (OR=0.59, p-value=0.03) appeared
to have a protective association with agitation/aggression, when compared to those who were in
age group <65 and had no history of seizures.
Table 3.2 evaluates the association between psychosis and TBI, stratified by the severity
of AD (mild, moderate, and severe). In this adjusted model, those with mild AD and psychosis
had an increased odds of being having and educational attainment of only 0-12 years (OR=1.67,
p-value=0.001) and recent urinary incontinence (OR=1.20, p-value=0.09), as compared to those
who had 18+ years of education and no urinary incontinence. While urinary incontinence was
not statistically significant, there was a suggestive association. Those with moderate AD and
psychosis had increased odds of being in age group 65-74, when compared to those who were
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<65 years, with a 45% increased odds (OR=1.45, p-value=0.03). In addition those with moderate
AD and psychosis had and increased odds of having only 0-12 and 13-16 years of educational
years, 76% increased odds (p-value=0.001) and 53% increased odds (p-value=0.01),
respectively. In those with severe AD and psychosis ages 85+ appeared to have a suggestive
protective association, with an OR of 0.67 (p-value=0.07) when compared to those <65 years of
age.

Discussion:
The purpose of this study was to assess whether TBI was a potential risk factor for psychiatric
symptoms in AD patients. There does not appear to be any significant association between TBI
and agitation/aggression at any level of AD severity. However, there are several covariates that
appeared to be significantly associated with agitation/aggression. It should be noted that while an
association was not found with TBI, this study had a pervasive statistical power issue, increasing
the probability of a Type II error—failure to find an association when one actually exists.
When AD was mild, there was a strong association with alcohol abuse and
agitation/aggression symptoms. However, this association disappeared as the severity of the AD
increased from moderate to severe. This result could occur because as the severity of AD
increases, the likelihood of a person having access to substances, or the faculties to maintain an
addiction, likely decrease. In contrast to those still actively abusing alcohol, as it is known that a
symptom of alcohol abuse is mood instability, and therefore it is likely that the abuse of alcohol
itself could be the cause of the agitation/aggression symptoms.
Those with mild AD also had increased odds in being in the age group 65-74; this could be
because people of this age are entering a time where independence post retirement becomes
important. However, with a diagnosis of AD, a person might feel they are losing their gained
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independence faster than those others of their age group. In addition, a loss of cognitive function
can be a big lifestyle change, causing anger and aggression. Another reason this age group could
be experiencing higher agitation/aggression could be the lack of properly trained elder care
workers working with those at this level of AD.
There also was an association between having active diabetes and having
agitation/aggression in both the mild and moderate states of AD. One explanation of this
association could be that when diabetes is not managed appropriately, diabetic shock may cause
mood instability, which could be misdiagnosed as a neuropsychiatric symptom caused by AD.
Though this association was not statistically significant, it could be a clinically significant
association.
A remote history of seizure with AD had one of the strongest associations with an odds
ratio of 2.24 for agitation/aggression, in those with moderate AD compared to those who did not
have a history of seizures. An explanation of this association could be that if seizures are severe
enough, it can cause brain damage affecting the centers of the brain responsible for agitation and
aggression symptoms. However, without more informed medical history on the severity of
seizures this association cannot be explored.
In those with severe AD and agitation/aggression, a protective association was found in
those age 85+ and in those with a recent history of urinary incontinence. This is likely due to the
fact that old age, urinary incontinence, and severe AD are all likely factors to cause
institutionalization; therefore they are likely receiving superior medical care as well as be highly
medicated to control their symptoms.
Psychosis was not significantly associated with TBI. In addition, those in the lowest
educational attainment group had the highest risk of developing psychosis, with 67% increased
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odds in people who had mild AD and 0-12 years of education, 76% increase in odds in people
who had moderate AD and 0-12 years of education, and 53% increase in odds in those who had
13-16 years of education. These findings could be attributed to the protective effect of education
and cognitive reserve, indicated by several studies; the higher the level of educational attainment,
the more protective cognitive reserve appears to be.30
At a mild stage of AD there is suggestive association between urinary incontinence and
having psychosis, with an increased odds of 20%. While not statistically significant, the p-values
were relatively close to 0.05. A study by Choudhury et al found that there was a statistically
significant increase in odds of having urinary incontinence in those with psychosis, as compared
to those who did not have psychosis, however it is important to note that no participants with
dementia participated in this study.29 Lastly, it appears that being age 85+ at a severe stage of AD
has a suggestive protective association in moderate AD. This result could be explained by an
increase in care. As those who are older and at a more severe stage of AD are more likely to be
institutionalized; therefore, it could be hypothesized that these individuals are receiving better
care than those who are younger and not incontinent.
Limitations
This study had many limitations. One main limitation was a lack of statistical power, due
to the small number of participants who reported a TBI (effect variable). There also was a large
amount of information bias. While the data provides information on TBIs with LOC or chronic
deficit, it does not record data on brain injuries without an LOC or TBIs that did not cause
noticeable deficits. In addition to this limitation, once a TBI is recorded, NACC does not record
the amount of TBIs each individual has incurred. This protocol could have led to an
underreporting of the amount of TBIs that were actually experienced. In addition to a possible
underreporting of TBIs, there also is no information on how each TBI was acquired. Loss to
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follow-up with this particular population may have been a problem due to the fact that all
participants are sampled at different times, leaving an incomplete picture of developed symptoms
as participants progress into worsening AD.
Selection bias also was problem, as a large proportion of people participating in the study
were white and college-educated. Therefore, the study population is not representative of the
overall population. Recall bias also could have played a role in this study, as information was not
always ascertained from the original participant, with some information provided by a coparticipant. In addition, there is a testing bias regarding the participants’ TBI status because no
medical confirmation of a TBI was required for version 1 and 2 of the NACC study, making it
difficult to know whether participants had repeated head injury.
Future Directions
This study evaluated the association between several potential variables and
psychological symptoms among AD patients. However, there are several directions that future
studies could take to further the understanding of TBIs and NPS in people with AD. One area of
importance would be examining the cellular and molecular changes that occur in patients who
have had a TBI and exploring whether there is a difference in those who had the exposure and
those who did not. The number of TBIs someone has experienced also is important, as this factor
addresses whether there is a dose-response curve with the number of TBIs and the severity of
symptoms experienced. A longitudinal prospective cohort study is also an area for future
research, as this design would allow a time to event to be calculated. Lastly, a study that removes
TBIs, which occurred after psychiatric symptoms started, could assess the time trend of the
exposure (TBI) and the outcome (psychosis and agitation/aggression). For the purpose of this
study, agitation and aggression were the only psychiatric symptoms analyzed, but an expansion
of psychological symptoms experienced could reveal other important connections, as there are
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many types of NPS that impact patients and caregivers. By expanding the types of symptoms
analyzed, there is the potential to enhance the holistic understanding of the effect of TBIs on
neuropsychological outcomes.

Conclusion:
This study did not find an association between TBI and psychiatric symptoms in persons
with AD. However, there appears to be an association with age (65-74 years), active diabetes,
active alcohol abuse, recent urinary incontinence, and a remote history of seizures and an
increase in the odds of having agitation/aggression. However, those with severe AD and a recent
history of seizures have decreased odds of developing agitation/aggression. In those with
psychosis, education 0-12 years in patients with mild AD, and in those with moderate AD age
65-74 years, education 0-12 years and 13-16 years, had increased odds of developing psychosis.
The limitations of this study reduce its ability to accurately assess possible associations between
TBI and psychiatric conditions in persons with AD.
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Appendix
Figure 1: Study participant breakdown

All Study Particpants
N=103,710

Participants with
Alzheimer's Disease

Participants without
Alzheimer's Disease

N=10,511

N=93,199

No History of
Traumatic Brain
Injury
N=9,439
History of Traumatic
Brain Injury
N=1,072
No Agitation/
Aggression and or
Psychosis

Agitation/Aggression
N=577
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Psychosis
N=280

Agitation/Aggression
N=4,819

Psychosis
N=2,377

No Agitation/
Aggression and or
Psychosis
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Table 1.1: Study Population Demographics

Sex
Male
Female
Age
<65
65-74
75-84
85+
Race (NACCHIHR)
White
Black or African American
American Indian or
Alaska Native
Asian/ Pacific Islander
Multiracial
Years of Education
0-12 yrs
(12=High School Diploma)
13-16 yrs
(16=Bachelors Degree)
17-18 yrs
(18=Masters Degree)
18<
(Doctoral Degree)
TBI Exposure
Brief Loss of
Consciousness
Extended Loss
Consciousness
Chronic Deficit
Alzheimer’s Disease Status
Mild (CDGLOB=1)
Moderate (CDGLOB=2)
Severe (CDGLOB=3)
Medical History
History of Stroke
Hypertension
Diabetes
Seizures
Urinary Incontinence
Substance Abuse History
Alcohol Abuse
Drug Use
Smoking Status
Ever Smoker
Never Smoked
Psychological State
Agitation & Aggression
Psychosis

University of Kentucky

TOTAL (N=10,511)
n (%)

TBI Positive (N=1,072)
n (%)

TBI Negative (N=9,439)
n (%)

4, 596 (43.7)
5, 915 (56.3)

646 (60.3)
426 (39.7)

3, 950 (41.8)
5, 489 (58.2)

1, 143 (10.9)
2, 294 (21.8)
43.62 (41.5)
2, 712 (25.8)

158 (14.7)
263 (24.5)
382 (35.6)
269 (25.1)

985 (10.4)
2, 031 (21.5)
3, 980 (42.2)
2,443 (25.9)

8, 451 (80.4)
1, 223 (11.6)
74 (0.7)

926 (86.3)
71 (6.6)
9 (0.8)

7, 525 (79.7)
1, 152 (1.6)
65 (0.7)

199 (1.9)
337 (3.2)

10 (0.9)
39 (3.6)

189 (2.0)
298 (3.2)

3, 997 (38.0)

355 (33.1)

3, 642 (38.6)

3, 935 (37.4)

415 (38.7)

3, 520 (37.3)

1, 497 (14.2)

174 (16.2)

1, 323 (14.0)

1, 082 (10.3)

128 (11.9)

954 (10.1)

808 (7.7)

808 (75.4)

--

292 (2.8)

292 (27.2)

--

66 (0.6)

66 (6.2)

--

3,737 (35.6)
2,779 (26.4)
2,103 (20.0)

377 (35.2)
272 (25.4)
222 (20.7)

3, 360 (35.6)
2, 507 (26.6)
1, 881 (19.9)

760 (7.2)
5, 274 (50.2)
1, 559 (14.8)
500 (4.8)
4, 029 (38.3)

77 (7.2)
499 (46.5)
155 (14.5)
98 (9.1)
471 (43.9)

683 (7.2)
4, 775 (50.6)
1, 404 (14.9)
402 (4.3)
3, 558 (37.7)

767 (7.3)
96 (0.9)

118 (11.0)
19 (1.8)

649 (6.9)
77 (0.8)

4, 552 (43.3)
5, 823 (55.4)

534 (49.8)
527 (49.2)

4, 018 (42.6)
5, 296 (56.1)

5, 396 (53.3)
2, 657 (26.3)

577 (53.8)
280 (26.1)

4, 819 (51.1)
2, 377 (25.2)
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Table 2.1: Bivariate analysis of agitation and aggression by severity of Alzheimer’s disease.

AD with Mild Impairment
CDRGLOB=1

AD with Moderate Impairment
CDRGLOB=2

N

OR (95% CI)

p-value

TBI Positive

191

1.06 (0.85-1.32)

0.59

No History of TBI

1678

--

--

N

OR (95% CI)

p-value

169

1.21 (0.94-1.57)

1472

--

AD with Severe Impairment
CDRGLOB=3
N

OR (95% CI)

p-value

0.15

124

1.07 (0.80-1.43)

0.67

--

1000

--

--

Head Injury (TBI) Exposure

Age
<65

196

--

--

173

--

--

133

--

--

65-74

474

1.42 (1.12-1.81)

0.004

334

1.16 (0.87-1.56)

0.32

241

0.97 (0.69-1.36)

0.85

75-84

829

1.13 (0.91-1.41)

0.26

675

1.02 (0.78-1.33)

0.90

415

0.90 (0.66-1.22)

0.49

22.87

0.97 (0.76-1.23)

0.79

414

0.75 (0.57-0.99)

0.04

335

0.75 (0.55-1.03)

0.07

0-12 yrs

736

1.16 (0.92-1.46)

0.20

654

1.16 (0.88-1.52)

0.29

449

0.99 (0.71-1.38)

0.96

13-16 yrs

680

0.94 (0.74-1.18)

0.57

572

1.11 (0.84-1.46)

0.46

405

0.85 (0.61-1.18)

0.32

17-18 yrs

263

0.96 (0.74-1.26)

0.78

225

1.26 (0.91-1.74)

0.17

163

0.96 (0.66-1.40)

0.83

18+ yrs

190

--

--

145

--

--

107

--

--

Diabetes (Recent)

270

1.24 (1.02-1.50)

0.03

227

1.26 (1.00-1.59)

0.05

157

1.11 (0.85-1.45)

0.44

Diabetes (Remote)

31

1.20 (0.71-2.04)

0.50

24

0.91 (0.49-1.67)

0.75

18

0.79 (0.40-1.54)

0.48

No Diabetes

1565

--

--

1341

--

--

945

--

--

History of Stroke

1618

1.13 (0.87-1.47)

0.35

149

1.14 (0.87-1.50)

0.35

86

1.11 (0.75-1.63)

0.61

No History of Stroke

136

--

--

1248

--

--

613

--

--

History of Seizures (Recent)

23

0.94 (0.53-1.68)

0.84

29

0.93 (0.53-1.62)

0.79

66

0.62 (0.440.87)

0.01
0.05

85+
Education

Health Conditions

History of Seizures (Remote)

33

1.24 (0.74-2.10)

0.42

30

1.76 (0.90-3.44)

0.10

39

0.64 (0.41-1.00)

No History of Seizures

1,801

--

--

1,532

--

--

1,011

--

--

Incontinence (Recent)*
Incontinence (Remote)*

389
69

1.07 (0.91-1.25)
1.11 (0.80-1.55)

0.44
0.53

593
53

1.05 (0.90-1.24)
0.96 (0.63-1.47)

0.53
0.85

802
22

0.66 (0.53-0.83)
0.74 (0.38-1.44)

0.0002
0.37

No Incontinence*

1394

--

--

945

--

297

--

--

Alcohol Abuse (Recent)

35

1.60 (0.93-2.77)

0.09

13

1.14 (0.47-2.75)

0.78

3

1.11 (0.19-6.67)

0.91

Alcohol Abuse (Remote)

124

1.30 (0.98-1.71)

0.07

105

0.99 (0.73-1.35)

0.96

83

1.12 (0.79-1.59)

0.53

No Alcohol Abuse

1703

--

--

1471

--

--

1033

--

--

2

0.63 (0.10-3.74)

0.61

1

0.35 (0.03-3.87)

0.39

0

N/A

N/A

14

0.77 (0.38-1.57)

0.47

13

2.28 (0.74-6.99)

0.15

8

0.59 (0.23-1.489)

0.26

1851

--

--

1575

--

--

1113

--

--

Substance Use

Drug Abuse (Recent)
Drug Abuse (Remote)
No Drug Abuse
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Table 2.2: Bivariate analysis of psychosis by severity of Alzheimer’s disease.

AD with Mild Impairment
CDRGLOB=1

AD with Moderate Impairment
CDRGLOB=2

AD with Severe Impairment
CDRGLOB=3

N

OR (95% CI)

p-value

N

OR (95% CI)

p-value

N

OR (95% CI)

p-value

TBI Positive

74

0.97 (0.74-1.26)

0.80

103

1.15 (0.89-1.49)

0.30

86

1.17 (0.87-1.56)

0.31

No History of TBI

688

--

--

860

--

--

649

--

--

Head Injury (TBI) Exposure

Age
<65

73

--

--

93

--

--

89

--

--

65-74

175

1.22 (0.90-1.65)

0.20

208

1.38 (1.02-.86)

0.04

150

0.87 (0.62-1.22)

0.42

75-84

342

1.28 (0.96-1.69)

0.09

416

1.25 (0.95-.64)

0.12

289

0.99 (0.73-1.35)

0.96

85+

172

1.19 (0.88-1.61)

0.26

246

0.97 (0.72-1.29)

0.81

207

0.73 (0.53-1.00)

0.05

0-12 yrs

341

1.70 (1.26-2.30)

0.0005

425

1.71 (1.26-2.30)

0.001

344

1.58 (1.13-2.22)

0.01

13-16 yrs

271

1.23 (0.91-1.66)

0.19

350

1.51 (1.11-2.04)

0.01

246

0.96 (0.68-1.36)

0.83

17-18 yrs

88

1.01 (0.71-1.44)

0.97

118

1.29 (0.91-1.83)

0.16

83

0.81 (0.54-1.20)

0.29

18+ yrs

62

--

--

70

--

--

62

--

--

Diabetes (Recent)

113

1.18 (0.94-1.48)

0.16

810

1.14 (0.91-1.44)

0.26

116

1.38 (1.06-1.79)

0.02

Diabetes (Remote)

9

0.73 (0.36-1.50)

0.40

136

0.80 (0.42-1.54)

0.50

14

1.15 (0.58-2.29)

0.68

638

--

--

13

--

--

603

--

--

History of Stroke

55

1.06 (0.77-1.44)

0.73

85

0.98 (0.74-1.30)

0.89

58

0.98 (0.67-1.41)

0.89

No History of Stroke

664

--

--

760

--

--

434

--

--

History of Seizures
(Recent)
History of Seizures
(Remote)
No History of Seizures

13

1.50 (0.78-2.86)

0.22

21

1.28 (0.73-2.25)

0.39

56

1.10

0.59

12

0.99 (0.52-1.88)

0.98

15

1.01 (0.54-1.92)

0.97

25

0.74

0.21

729

--

--

923

--

--

645

--

--

Incontinence (Recent)*

177

1.23 (1.01-1.49)

0.04

366

1.07 (0.91-1.27)

0.39

535

0.85 (0.69-1.05)

0.14

Incontinence (Remote)*

24

0.75 (0.48-1.17)

0.21

24

0.65 (0.40-1.04)

0.07

14

0.85 (0.43-1.68)

0.63

No Incontinence*

557

--

--

569

--

--

186

--

--

Alcohol Abuse (Recent)

12

1.03 (0.54-1.97)

0.92

5

0.57 (0.21-1.56)

0.27

4

6.66 (0.74-59.65)

0.09

Alcohol Abuse (Remote)

49

1.11 (0.80-1.54)

0.53

63

0.99 (0.72-1.35)

0.93

53

1.04 (0.73-1.47)

0.83

No Alcohol Abuse

698

--

--

888

--

--

674

--

--

0

0.96

1

0.91 (0.08- 10.08)

0.94

0

N/A

N/A

8

<0.001 (<0.001
>999.999)
1.31 (0.58-2.94)

0.51

6

1.00 0.37-2.70)

0.99

7

1.05 (0.41-2.72)

0.92

753

--

--

949

--

--

727

--

--

Education

Health Conditions

No Diabetes

Substance Use

Drug Abuse (Recent)
Drug Abuse (Remote)
No Drug Abuse
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Table 3.1: Multivariate analysis of agitation and aggression by severity of Alzheimer’s
disease
AD with Mild Impairment
CDRGLOB=1

AD with Moderate Impairment
CDRGLOB=2

AD with Severe Impairment
CDRGLOB=3

OR (95% CI)

p-value

OR (95% CI)

p-value

OR (95% CI)

p-value

1.11 (0.89-1.41)

0.35

1.05 (0.78-1.42)

0.74

0.99 (0.64-1.54)

0.97

--

--

--

--

--

--

<65
65-74

-1.41 (1.10-1.81)

-0.007

-1.19 (0.87-1.84)

-0.27

-1.11 (0.68-1.80)

-0.68

75-84

1.12 (0.89-1.41)

0.35

1.07 (0.80-1.43)

0.64

0.82 (0.53-1.27)

0.37

85+

0.94 (0.73-1.21)

0.62

0.80 (0.59-1.09)

0.16

0.66 (0.42-1.04)

0.07

0-12 yrs
13-16 yrs

1.15 (0.90-1.46)
0.93 (0.73-1.18)

0.26
0.55

1.18 (0.87-1.59)
1.12 (0.83-1.52)

0.28
0.46

1.04 (0.63-1.69)
0.87 (0.53-1.42)

0.89
0.57

17-18 yrs

0.99 (0.75-1.01)

0.93

1.28 (0.90-1.84)

0.18

0.78 (0.44-1.39)

0.40

--

--

--

--

--

--

1.21 (0.99-1.49)
1.08 (0.62-1.89)

0.07
0.78

1.25 (0.97-1.61)
0.99 (0.50-1.95)

0.08
0.98

1.02 (0.72-1.46)
0.87 (0.33-2.29)

0.90
0.77

Head Injury (TBI) Exposure
TBI Positive
No History of TBI
Age

Education

18+ yrs
Health Conditions
Diabetes (Recent)
Diabetes (Remote)
No Diabetes

--

--

--

--

--

--

History of Stroke
No History of Stroke

1.19 (0.91-1.55)
--

0.20
--

1.20 (0.90-1.60)
--

0.20
--

1.30 (0.86-1.97)
--

0.21
--

History of Seizures (Recent)
History of Seizures (Remote)

1.02 (0.55-1.90)
1.52 (0.86-2.68)

0.94
0.15

0.89 (0.47-1.69)
2.24 (1.01-4.99)

0.72
0.05

0.59 (0.37-0.96)
0.74 (0.36-1.54)

0.03
0.42

No History of Seizures

--

--

--

--

--

--

Incontinence (Recent)*

1.06 (0.89-1.26)

0.55

1.18 (0.98-1.41)

0.08

0.88 (0.66-1.18)

0.38

Incontinence (Remote)*
No Incontinence*

1.15 (0.79-1.66)
--

0.47
--

1.04 (0.65-1.68)
--

0.87
--

0.68 (0.28-1.69)
--

0.41
--

Alcohol Abuse (Recent)

1.87 (1.03-3.40)

0.04

1.45 (0.55-3.86)

0.45

0.73 (0.12-4.53)

0.73

Alcohol Abuse (Remote)

0.77 (0.36-1.65)

0.15

0.87 (0.62-1.23)

0.44

1.22 (0.71-2.09)

0.47

--

--

--

--

--

--

Drug Abuse (Recent)

0.17 (.02-1.75)

0.14

0.85 (0.05-13.71)

0.91

NA

NA

Drug Abuse (Remote)
No Drug Abuse

0.77 (0.36-1.65)
--

0.50
--

1.99 (0.61-6.46)
--

0.25
--

0.46 (0.14-1.51)
--

0.20
--

Substance Use

No Alcohol Abuse

*Urinary Incontinence
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Table 3.2: Multivariate analysis of psychosis by severity of Alzheimer’s disease.
AD with Mild Impairment
CDRGLOB=1

AD with Moderate Impairment
CDRGLOB=2

AD with Severe Impairment
CDRGLOB=3

OR (95% CI)

p-value

OR (95% CI)

p-value

OR (95% CI)

p-value

0.94 (0.71-1.26)

0.68

1.22 (0.90-1.65)

0.20

1.02 (0.67-1.55)

0.93

--

--

--

--

--

--

Head Injury (TBI) Exposure
TBI Positive
No History of TBI
Age
<65

--

--

--

--

--

--

65-74

1.24 (0.90-1.71)

0.19

1.45 (1.04-2.02)

0.03

0.87 (0.55-1.37)

0.55

75-84

1.28 (0.95-1.72)

0.11

1.29 (0.95-1.76)

0.10

0.94 (0.62-1.43)

0.78

85+

1.16 (0.83-1.61)

0.39

1.00 (0.72-1.38)

0.98

0.67 (0.43-1.04)

0.07

0-12 yrs

1.67 (1.22-2.28)

0.001

1.76 (1.27-2.45)

0.001

1.45 (0.91-2.31)

0.12

13-16 yrs

1.23 (0.90-1.69)

0.19

1.53 (1.10-2.13)

0.01

0.85 (0.53-1.36)

0.49

17-18 yrs

0.96 (0.66-1.40)

0.85

1.29 (0.88-1.91)

0.20

0.65 (0.37-1.14)

0.13

--

--

--

--

--

--

Diabetes (Recent)

1.13 (0.89-1.43)

0.34

1.11 (0.86-1.42)

0.43

1.11 (0.79-1.56)

0.55

Diabetes (Remote)

0.77 (0.37-1.59)

0.47

0.89 (0.44-1.80)

0.74

0.96 (0.36-2.52)

0.93

--

--

--

--

--

--

1.01 (0.73-1.39)

0.95

0.94 (0.70-1.25)

0.49

0.98 (0.66-1.44)

0.90

Education

18+ yrs
Health Conditions

No Diabetes
History of Stroke
No History of Stroke

--

--

--

--

--

--

History of Seizures (Recent)

1.153 (0.77-3.03)

0.22

1.38 (0.73-2.64)

0.32

1.47 (0.90-2.39)

0.12

History of Seizures (Remote)

1.20 (0.62-2.32)

0.59

1.21 (0.61-2.43)

0.58

0.63 (0.30-1.34)

0.23

No History of Seizures

--

--

--

--

--

--

Incontinence (Recent)*
Incontinence (Remote)*

1.20 (0.97-1.48)
0.75 (0.46-1.23)

0.09
0.26

1.14 (0.95-1.37)
0.65 (0.38-1.11)

0.17
0.11

0.91 (0.69-1.20)
1.30 (0.53-3.21)

0.50
0.57

--

--

--

--

--

--

Alcohol Abuse (Recent)

1.09 (0.55-2.15)

0.81

0.46 (0.15-1.40)

0.17

4.93 (0.54-45.51)

0.16

Alcohol Abuse (Remote)

1.08 (0.76-1.54)

0.65

0.89 (0.63-1.28)

0.54

1.18 (0.72-1.96)

0.51

No Incontinence*
Substance Use

No Alcohol Abuse

--

--

--

--

--

--

Drug Abuse (Recent)

<0.001 (<0.001- >999.999)

0.97

1.99 (0.12-32.03)

0.63

N/A

N/A

Drug Abuse (Remote)

1.67 (0.72-3.90)

0.24

0.66 (0.20-2.14)

0.49

0.92 (0.28-2.99)

0.88

--

--

--

--

--

No Drug Abuse

--

*Urinary Incontinence
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